116 related articles for article (PubMed ID: 29120119)
1. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
Barić A; Marković V; Eterović D; Bedeković V; Kontić M; Juretić Kuščić L; Pešutić Pisac V; Punda A
Acta Clin Croat; 2017 Mar; 56(1):15-20. PubMed ID: 29120119
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
5. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
6. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.
Ito Y; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Oncology; 2005; 68(2-3):87-96. PubMed ID: 15886500
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification.
Khoo ML; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1810-3. PubMed ID: 11932322
[TBL] [Abstract][Full Text] [Related]
10. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis.
Wang S; Wuu J; Savas L; Patwardhan N; Khan A
Hum Pathol; 1998 Nov; 29(11):1304-9. PubMed ID: 9824112
[TBL] [Abstract][Full Text] [Related]
11. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications.
Pickett CA; Agoff SN; Widman TJ; Bronner MP
Thyroid; 2005 May; 15(5):461-73. PubMed ID: 15929668
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis.
Piana S; Ragazzi M; Tallini G; de Biase D; Ciarrocchi A; Frasoldati A; Rosai J
Hum Pathol; 2013 Apr; 44(4):556-65. PubMed ID: 23079204
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of the immunohistochemical analysis of several molecular markers in the characterization of papillary thyroid carcinoma with initial lymph node metastasis].
Zafón C; Castellví J; Obiols G
Endocrinol Nutr; 2010 Apr; 57(4):165-9. PubMed ID: 20403734
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
Mishra A; Agrawal V; Krishnani N; Mishra SK
J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Temmim L; Ebraheem AK; Baker H; Sinowatz F
Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.
Kim JY; Cho H; Rhee BD; Kim HY
Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030
[TBL] [Abstract][Full Text] [Related]
20. RET EXPRESSION AND ITS CORRELATION WITH CLINICOPATHOLOGIC DATA IN PAPILLARY THYROID CARCINOMA.
Punda A; Bedeković V; Barić A; Kontić M; Čolović Z; Vanjaka Rogošić L; Punda H; Kunac N; Grandić L; Pešutić Pisac V
Acta Clin Croat; 2018 Dec; 57(4):646-652. PubMed ID: 31168201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
